New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
12:28 EDTGALE, NLSN, RGR, ARB, GTAT, SWHCOn The Fly: Midday Wrap
Stocks on Wall Street were markedly higher at midday as optimism surrounding the fiscal cliff negotiations continues to spur buying. Investors have been paying less attention to recent economic reports to focus instead on the fiscal cliff, as demonstrated by the NAHB Housing Market index prompting little reaction, despite its highest reading since April 2006. The averages moved to session highs following comments from both sides of Washington's negotiating table that they hope a deal can still be reached... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as a Wall Street Journal cover story highlighted some of the ways American companies are distancing themselves from guns and their makers amid a public outcry in the aftermath of last week's tragedy in Connecticut. Among the recent developments underscored was the decision from private equity firm Cerberus Capital Management to put gunmaker Freedom Group up for sale... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up over 23% after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also rose about 3%. Among the noteworthy losers was Galena Biopharma (GALE), down 17% after it sold common stock and warrants to purchase additional shares in a public offering. Also lower was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw its shares slide more than 12% after issuing guidance well below Street expectations... INDICES: Near noon, the Dow was up 83.20, or 0.63%, to 13,318.59; the Nasdaq was up 33.89, or 1.13%, to 3,044.49; and the S&P 500 was up 11.60, or 0.81%, to 1,441.96.
News For ARB;NLSN;SWHC;RGR;GALE;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
09:17 EDTGALEOn The Fly: Pre-market Movers
Subscribe for More Information
November 20, 2014
16:22 EDTGALEGalena announces $55M purchase agreement with Lincoln Park Capital
Galena Biopharma announced the execution of a purchase agreement for up to $55M with Lincoln Park Capital Fund, a Chicago-based institutional investor. Under the terms of the purchase agreement dated November 18, LPC initially purchased $5M of Galena common stock at a price of $2.00 per share, 9% higher than the market close as of November 18, 2014. Thereafter, at its sole discretion, Galena may sell up to $50M worth of common stock to LPC over the 36-month term of the purchase agreement, subject to the conditions and limitations set forth in the purchase agreement. Under the terms of the purchase agreement, LPC will not cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of Galena common stock and is obligated to purchase at times and amounts controlled by the company. In consideration for entering into the agreement the company issued shares of its common stock to LPC as a commitment fee. Galena plans to use the proceeds received for its commercial and product development activities and for other working capital and general corporate purposes.
06:28 EDTNLSNBillboard 200 chart to include on-demand streaming in rankings
The Billboard 200 albums chart will premiere its biggest upgrade in more than 23 years, transforming from a pure sales-based ranking to one measuring multi-metric consumption. Beginning with the top 10 revealed on Wednesday, Dec. 3, on Billboard.com, the chart, which currently tracks the top 200 albums of the week by sales alone, will be the first to include on-demand streaming and digital track sales -- as measured by Nielsen Entertainment (NLSN) -- by way of a new algorithm. It is the most substantial methodology update since May 1991, when Billboard first used Nielsen's point-of-sale data -- SoundScan -- to measure album sales. The updated Billboard 200 will utilize accepted industry benchmarks for digital and streaming data, equating 10 digital track sales from an album to one equivalent album sale, and 1,500 song streams from an album to one equivalent album sale. All of the major on-demand audio subscription services are considered, including Spotify, Beats Music (AAPL), Google Play (GOOG) and Xbox Music (MSFT). Reference Link
November 19, 2014
12:43 EDTNLSNRentrak weakness on Nielsen news misplaced, says Brean Capital
Subscribe for More Information
06:34 EDTNLSNNielsen to begin measuring viewing of subscription video services, WSJ reports
Subscribe for More Information
November 18, 2014
07:37 EDTGALEStifel to hold a conference
Subscribe for More Information
07:09 EDTGALEGalena completes enrollment in GALE-401 Phase 2 clinical trial
Galena Biopharma announced the completion of enrollment in the GALE-401, or Anagrelide Controlled Release, Phase 2 Clinical Trial. The Phase 2, clinical proof-of-concept study is treating 18 patients with elevated platelet counts in myeloproliferative neoplasms, or MPNs, including Essential Thrombocythemia, or ET, Polycythemia Vera, or PV, and Primary Myelofibrosis, or PMF. The Phase 2 trial is an open-label, single-arm, multicenter study designed to confirm the platelet-lowering activity of GALE-401 in patients with MPNs, to assess safety and tolerability, and to measure plasma concentrations of anagrelide. The platelet lowering ability of GALE-401 will be measured by the proportion of patients that achieve a complete or partial platelet response for at least four weeks during 24 weeks of treatment. With enrollment complete, patients will now be followed for platelet response while they continue study treatment.
November 14, 2014
06:43 EDTNLSNViacom CEO: Nielsen's ratings haven't kept up with trends, NY Times says
Subscribe for More Information
November 12, 2014
08:19 EDTNLSNJPMorgan to hold a conference
Subscribe for More Information
November 11, 2014
09:17 EDTGALEOn The Fly: Pre-market Movers
UP AFTER EARNINGS: FMSA Holdings (FMSA), up 4.7% following third quarter results. ALSO HIGHER: AVEO Pharmaceuticals (AVEO), up 7.6% after entering agreement with Ophthotech (OPHT) to license tivozanib... Ophthotech is 2.1% higher in pre-market trading... Galena Biopharma (GALE), up 3.6% after first patient dosed in NeuVax and Herceptin combination Phase 2 trial... Yamana Gold (AUY), up 3% after being upgraded to Overweight from Neutral at HSBC... Ambac Financial (AMBC), up 3.1% after being upgraded to Neutral from Sell at MKM Partners... China Finance (JRJC), up 12.4% after announcing a new partnership with Great Wall Securities... Zynga (ZNGA), up 5.7% after being upgraded on mobile business growth at Jefferies... Fiat Chrysler (FCAU), up 2.2% after being initiated with a Conviction Buy at Goldman. DOWN AFTER EARNINGS: Applied Optoelectronics (AAOI), down 10.7%... Ekso Bionics (EKSO), down 2.2%. ALSO LOWER: Alibaba Group (BABA), down 1.6% following comments made by vice chairman Joseph Tsai in an interview.
07:06 EDTGALEGalena doses first patient in NeuVax, Herceptin combination Phase 2 trial
Subscribe for More Information
November 10, 2014
13:18 EDTGALEGalena terminates Brian Hamilton as Chief Medical Officer
Subscribe for More Information
06:27 EDTGTATGT Advanced accuses Apple of 'bait-and-switch' in unsealed documents, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use